QuanFu Biotech announced the completion of its capital reduction registration following the cancellation of employee stock rights shares. This adjustment has modified the company's stated capital and outstanding shares, leading to a slight increase in net asset per share.
Please note: As an AI, I cannot perform real-time translation of the full article body. This section would contain the complete English translation of the press release, including all details from the original Japanese text.
FACT BOX
- Source: PR Times
- Category: 人事